Trump vows to lower drug prices — pharma, biotech stocks drop
(By Mackenzie Bean for Becker’s Hospital Review) President-elect Donald Trump Wednesday pledged to tackle high drug prices in an interview
Read More
Part D/Prescription Drugs
Medicare: Do Not Make These Mistakes
Kimberly Lankford, Contributing Editor for Kiplinger, gives advice on ways to avoid eleven common Medicare mistakes. Read article here… Notice:
Read MoreImmunotherapies move beyond cancer, with first foray into sepsis
(By Asher Mullard for STAT) Drug developers have tried for decades without success to develop treatments for sepsis, a brutal infection
Read MoreDo I Still Need Medicare Part D?
In Kiplinger’s Ask Kim column, Kimberly Lankford answers the reader’s question on whether or not they need Medicare Part D
Read MoreSeniors Increasingly Getting High, Study Shows
(By Carmen Heredia Rodriguez for Kaiser Health News) Baby boomers are getting high in increasing numbers, reflecting growing acceptance of the
Read MoreNovo Nordisk becomes second major drug maker to limit price hikes
(By Ed Silverman for STAT) Yet another major drug maker is pledging to limit price hikes. Continue reading article here…
Read MoreDon’t Miss This Deadline!
December 7th is the deadline to switch from traditional Medicare to a Medicare Advantage plan effective for January 2017. Read
Read MoreMagic mushrooms drug shown to ease cancer patients’ depression
(By Bob Tedeschi for STAT) he US medical community is slowly embracing marijuana. Will magic mushrooms be next? Continue reading
Read MoreMylan CEO accepts full responsibility for EpiPen price hikes, but offers little explanation
(By Ed Silverman for STAT) In a rare appearance since the EpiPen controversy flared this summer, Mylan Pharmaceuticals CEO Heather Bresch accepted
Read MoreThe drug industry’s stake in Trumpcare is bigger than you think
(By Dylan Scott for STAT) WASHINGTON — The upcoming fight over repealing and replacing the Affordable Care Act1 promises to
Read More